DSM-5 in New Scientist: Psychiatry’s new diagnostic bible is creating headaches for doctors and patients alike

DSM-5 in New Scientist: “Psychiatry’s new diagnostic bible is creating headaches for doctors and patients alike”

Post #171 Shortlink: http://wp.me/pKrrB-293

A reminder that this third and final stakeholder review and comment period is scheduled to close on June 15.

On May 17, APA added the following statement to the home page of the DSM-5 Development site.

APA Position Statement on DSM-5 Draft Diagnostic Criteria

The official position of the APA on draft DSM-5 diagnostic criteria is that they are not to be used for clinical or billing purposes under any circumstances. They are published on the http://www.dsm5.org Web site to obtain feedback on these preliminary DSM-5 Task Force proposals from mental health professionals, patients, and the general public. They have not received official reviews or approval by the APA Board of Trustees and will not be available for clinical use or billing purposes until May 2013.

Two articles in this week’s online and print editions of New Scientist.

The first report, by Peter Aldhous, quotes Allen Frances, MD, who had chaired the development of the DSM-IV; APA research director and DSM-5 Task Force Vice Chair, Darrel Regier, and Dr Dayle Jones who is tracking DSM-5 for the American Counseling Association, on DSM-5 field trial kappa results and the relegation of Attenuated psychosis syndrome and Mixed anxiety/depression to the DSM-5 appendix.

This article is behind a paywall or a subscription to the print edition.

New Scientist 19 May 2012

Page 6 print edition

THIS WEEK/MENTAL HEALTH

Psychiatry’s new diagnostic bible is creating headaches for doctors and patients alike

Online title Trials highlight worrying flaws in psychiatry ‘bible’

Peter Aldhous

Diagnosis: uncertain

HOW reliable is reliable enough?

The second article, “OPINION ‘Label jars, not people”, by James Davies, is accessible on the New Scientist website without payment or print edition subscription.

New Scientist 19 May 2012

Page 7 print edition

OPINION | James Davies

James Davies is a senior lecturer in social anthropology and psychotherapy at the University of Roehampton, London

‘Label jars, not people’

“LABEL jars, not people” and “stop medicalising the normal symptoms of life” read placards, as hundreds of protesters – including former patients, academics and doctors – gathered to lobby the American Psychiatric Association’s (APA) annual meeting.

The demonstration aimed to highlight the harm the protesters believe psychiatry is perpetrating in the name of healing. One concern is that while psychiatric medications are more widely prescribed than almost any drugs in history, they often don’t work well and have debilitating side effects. Psychiatry also professes to respect human rights, while regularly treating people against their will. Finally, psychiatry keeps expanding its list of disorders without solid scientific justification…

Read full article

Advertisements

Criticism of DSM-5 proposals for grief in this week’s Lancet: Editorial and Essay

Criticism of DSM-5 proposals for grief in this week’s Lancet: Editorial and Essay

Post #143 Shortlink: http://wp.me/pKrrB-1Um

Update:

Christopher Lane Ph.D. has blogged at Side Effects at Psychology Today

Side Effects
From quirky to serious, trends in psychology and psychiatry.
by Christopher Lane, Ph.D.

Good Grief: The APA Plans to Give the Bereaved Two Weeks to Conclude Their Mourning

Britain’s “Lancet” calls the proposal “dangerously simplistic and flawed.”

Published on February 17, 2012 by Christopher Lane, Ph.D. in Side Effects

Allan Frances, MD, former chair of DSM-IV Task Force has blogged in DSM5 in Distress at Psychology Today

DSM5 in Distress
The DSM’s impact on mental health practice and research.
by Allen Frances, M.D.

Lancet Rejects Grief As a Mental Disorder

Will DSM 5 Finally Drop This Terrible Idea

Published on February 17, 2012 by Allen J. Frances, M.D. in DSM5 in Distress

 

This week in the Lancet

The lead Editorial in this week’s Lancet expresses concerns about specific proposals for the next edition of the American Psychiatric Association’s Diagnostic and Statistical Manual of Mental Disorders.

The misclassification of grief as a mental illness

An Editorial expresses concerns about the forthcoming fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5). While previous editions of DSM have highlighted the need to consider, and usually exclude, bereavement before diagnosis of a major depressive disorder, the current draft of this fifth edition fails to do that. In this week’s The Art of Medicine Arthur Kleinma reflects on his own personal experiences of grief and continues the discussion on the classification of grief as a mental illness. Finally, a Comment asks if attenuated psychosis syndrome should be included in DSM-5.

Lancet Editorial: Grief is not an illness and should not be routinely treated with antidepressants (Full text)

The Lancet, Volume 379, Issue 9816, Page 589, 18 February 2012 doi:10.1016/S0140-6736(12)60248-7 
http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(12)60248-7/fulltext

Also includes reference to ICD-11:

“WHO’s International Classification of Diseases, currently under revision as ICD-11, is debating a proposal to include “prolonged grief disorder”, but it will be another 18 months before that definition will be clear.” Editorial, The Lancet, Page 589, 18 February 2012

Essay: Culture, bereavement, and psychiatry (Full text)

The Lancet, Volume 379, Issue 9816, Pages 608 – 609, 18 February 2012 doi:10.1016/S0140-6736(12)60258-X
http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(12)60258-X/fulltext

Comment: Should attenuated psychosis syndrome be included in DSM-5? (Subscription or payment required)

The Lancet, Volume 379, Issue 9816, Pages 591 – 592, 18 February 2012 doi:10.1016/S0140-6736(11)61507-9
http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(11)61507-9/fulltext

Previous Lancet article on DSM-5

The first flight of DSM-5 | Niall Boyce

The Lancet, Volume 377, Issue 9780, Pages 1816 – 1817, 28 May 2011 doi:10.1016/S0140-6736(11)60743-5

%d bloggers like this: